Dermaseptin Peptide Derivatives Kill MDR Klebsiella and Staph at Low Concentrations
Four dermaseptin S4 and B2 derivatives showed antibacterial activity against MDR K. pneumoniae and S. epidermidis with MICs of 6.25-25 μg/mL and concentration-dependent cytotoxicity.
Quick Facts
What This Study Found
Four dermaseptin derivatives (K4K20S4, K4S4(1-16), B2, K3K4B2) showed MICs 6.25-25 μg/mL and MBCs 12.5-50 μg/mL against MDR K. pneumoniae and S. epidermidis, with concentration-dependent cytotoxicity.
Key Numbers
How They Did This
Synthesis of four dermaseptin S4/B2 derivatives, MIC/MBC determination against MDR K. pneumoniae and S. epidermidis, and cytotoxicity assessment via MTT assay on HEp-2 cells.
Why This Research Matters
K. pneumoniae and S. epidermidis cause devastating hospital infections with increasingly limited antibiotic options. Frog-derived peptide alternatives could fill this gap.
The Bigger Picture
Frog skin remains one of nature's richest sources of antimicrobial peptides, with dermaseptins showing consistently promising activity against hospital superbugs.
What This Study Doesn't Tell Us
In vitro only. Therapeutic window between antimicrobial and cytotoxic concentrations needs optimization. In vivo efficacy not tested.
Questions This Raises
- ?Can the therapeutic window be improved through further sequence optimization?
- ?Would these derivatives show activity against other ESKAPE pathogens?
- ?What is the mechanism of action enabling dual Gram-positive/negative activity?
Trust & Context
- Key Stat:
- 6.25-25 μg/mL MIC Frog-derived peptide derivatives effective against two major MDR hospital pathogens at therapeutically relevant concentrations
- Evidence Grade:
- Standard in vitro AMP characterization. Promising activity levels needing in vivo validation.
- Study Age:
- Published in 2025.
- Original Title:
- Antibacterial activity of peptide derivatives of dermaseptins against multidrug-resistant Klebsiella pneumoniae and Staphylococcus epidermis.
- Published In:
- Biochemistry and biophysics reports, 45, 102449 (2026)
- Authors:
- Haddad, Houda, Al-Rashidi, Reyadh R, Loghmari, Ahmed, Sahtout, Wissal, Boukadida, Raja, Dahmene, Rihem, Ettouil, Emeny, Othman, Houcemeddine, Ouahchi, Ines, Zaϊri, Amira
- Database ID:
- RPEP-15248
Evidence Hierarchy
Frequently Asked Questions
What are dermaseptins?
Antimicrobial peptides naturally produced in frog skin. They evolved over millions of years to protect frogs from skin infections and show potent activity against bacteria that resist human antibiotics.
Can frog peptides treat human infections?
In the lab, yes — these derivatives kill two of the most dangerous hospital bacteria at low concentrations. Further development is needed to create formulations suitable for treating human infections.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15248APA
Haddad, Houda; Al-Rashidi, Reyadh R; Loghmari, Ahmed; Sahtout, Wissal; Boukadida, Raja; Dahmene, Rihem; Ettouil, Emeny; Othman, Houcemeddine; Ouahchi, Ines; Zaϊri, Amira. (2026). Antibacterial activity of peptide derivatives of dermaseptins against multidrug-resistant Klebsiella pneumoniae and Staphylococcus epidermis.. Biochemistry and biophysics reports, 45, 102449. https://doi.org/10.1016/j.bbrep.2026.102449
MLA
Haddad, Houda, et al. "Antibacterial activity of peptide derivatives of dermaseptins against multidrug-resistant Klebsiella pneumoniae and Staphylococcus epidermis.." Biochemistry and biophysics reports, 2026. https://doi.org/10.1016/j.bbrep.2026.102449
RethinkPeptides
RethinkPeptides Research Database. "Antibacterial activity of peptide derivatives of dermaseptin..." RPEP-15248. Retrieved from https://rethinkpeptides.com/research/haddad-2026-antibacterial-activity-of-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.